Immunorestitution disease involving the innate and adaptive response

Clinical Infectious Diseases

Volumn 30, Issue 6, 2000, Pages 882-892

  Cheng, Vincent C C ^a   Yuen, Kwok Yung ^a   Chan, Wai Ming ^a   Ma, Edmond S K ^a   Chan, Robert M T ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CEFTAZIDIME; CORTICOSTEROID; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; METYRAPONE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS TERREUS; CANDIDIASIS; CASE REPORT; CORTICOSTEROID THERAPY; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS; DOSE RESPONSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNORESTITUTION DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MYCOBACTERIOSIS; NEUTROPHIL; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL;

ADULT; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS;

EID: 0034463167     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313809     Document Type: Article

References (49)

1. Recovery of the immune system with antiretroviral therapy: The end of opportunism?
2. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
3. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS
4. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: A new syndrome
5. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis
6. Paradoxical reactions in HIV and pulmonary TB
7. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
8. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS
9. Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR
10. Detection of CMV DNA in bone marrow transplant recipients: Plasma versus leucocyte polymerase chain reaction
11. Direct detection of cytomegalovirus in peripheral blood leukocytes: A review of the antigenemia assay and polymerase chain reaction
12. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy
13. Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy
14. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier
15. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy
16. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers
17. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients
18. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy
19. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B
20. Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency
21. Hepatitis B associated liver failure following bone marrow transplantation
22. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation
23. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis: Influence of bone marrow recovery in patients with acute leukemia
24. Fatal haemoptysis in pulmonary filamentous mycosis: An underevaluated cause of death in patients with acute leukaemia in haematological complete remission: A retrospective study and review of the literature. Gimema Infection Program
25. Invasive aspergillosis in neutropenic patients: Rapid neutrophil recovery is a risk factor for severe pulmonary complications
26. Hepaticcandidiasis in cancer patients: The evolving picture of the syndrome
27. Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia
28. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor
29. Hepatitis C virus - Associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
30. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
31. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
32. HIV combination therapy: Partial immune restitution unmasking latent cryptococcal infection
33. HIV combination therapy: Immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy
34. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome
35. Stage-specific manifestation of mold infections in bone marrow transplant recipients: Risk factors and clinical significance of positive concentrated smears
36. Immune reconstitution in HIV infection
37. Human immunodeficiency virus disease: Changing patterns of intraocular inflammation
38. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease
39. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B
40. The spectrum of hepatic candidiasis
41. Chronic systemic candidiasis
42. Fungal infections in the pediatric cancer patient
43. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
44. Severe candidal infections in neutropenic patients
45. Tuberculosis in patients infected with human immunodeficiency virus: Perspective on the past decade
46. Cavitary pulmonary lesions in patients infected with human immunodeficiency virus
47. Tratment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: Experience of European Bone Marrow Transplant Group
48. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death
49. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor